Sibutramine (trade name Meridia in the USA, Reductil in Europe and other countries), usually as sibutramide hydrochloride monohydrate, is an orally administered agent for the treatment of obesity. It is a centrally acting stimulant chemically related to amphetamines thus it is classified as a Schedule IV controlled substance in the United States. In October 2010, Sibutramine was withdrawn from Canadian and U.S. markets due to concerns that the drug increases the risk of heart attack and stroke in patients with a history of heart disease.

Filter

Showing 1–12 of 17 results

  • Placeholder

    NOBESE 10mg Capsule 14s

    Antiobesity preparations  280.00
  • REDUCTIL 10mg Capsule 14s

    REDUCTIL 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     835.00
  • Placeholder

    ACCENT 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     350.00
  • Placeholder

    SIBURA 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     275.00
  • Placeholder

    MERIDA 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     350.00
  • Placeholder

    TRIM FAST 10mg Capsule 2x7s

    Antiobesity preparations
    Rated 0 out of 5
     350.00
  • Placeholder

    OBERID 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     350.00
  • Placeholder

    SLIMER 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     210.00
  • Placeholder

    SLIMFIG 10mg Capsule 2x7s

    Antiobesity preparations  350.00
  • Placeholder

    SIBESY 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     350.00
  • Placeholder

    KALGRAY 10mg Capsule 2x7s

    Antiobesity preparations
    Rated 0 out of 5
     350.00
  • Placeholder

    GETSET 10mg Capsule 14s

    Antiobesity preparations
    Rated 0 out of 5
     280.00
Shopping Cart